Search

Your search keyword '"John F.R. Robertson"' showing total 9 results
Start Over Author "John F.R. Robertson" Journal chest
9 results on '"John F.R. Robertson"'

1. EarlyCDT ® -Lung Enhances the Positive Predictive Power of Computed Tomography for Detecting Lung Cancer

Author

William Jewell, Laura J. Peek, William W. Pingleton, Lynn Fredericks, and John F.R. Robertson

Subjects
Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung, medicine.diagnostic_test, business.industry, Computed tomography, Critical Care and Intensive Care Medicine, medicine.disease, medicine.anatomical_structure, medicine, Predictive power, Radiology, Cardiology and Cardiovascular Medicine, Lung cancer, business
Published
2012

2. The Additive Effect of the Stratified EarlyCDT ® -Lung Serum Autoantibody Test on the Assessment of Lung Cancer Risk

Author

Lynn Fredericks, John F.R. Robertson, Graham F. Healey, Geoffrey Hamilton-Fairley, and Laura J. Peek

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung, business.industry, Autoantibody, Critical Care and Intensive Care Medicine, medicine.disease, medicine.anatomical_structure, Internal medicine, Autoantibody test, Additive drug effects, Immunology, medicine, Cardiology and Cardiovascular Medicine, business, Lung cancer
Published
2012

3. Antigen Positivity in the Early CDT-Lung Test by Stage and Histological Subtype of Lung Cancer

Author

Peter Boyle, John F.R. Robertson, Laura J. Peek, Caroline J. Chapman, Paul Maddison, Graham F. Healey, Stephen Lam, Andrea Murray, and William C. Wood

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Pathology, Lung, business.industry, Decongestive lymphatic therapy, Critical Care and Intensive Care Medicine, medicine.disease, medicine.anatomical_structure, Antigen, Internal medicine, medicine, Stage (cooking), Cardiology and Cardiovascular Medicine, business, Lung cancer
Published
2010

4. Reproducibility of Autoantibody Measurements in Normal Individuals Using the Early CDT-Lung Test

Author

Jane McElveen, George Parsons, John F.R. Robertson, Jared Allen, Andrea Murray, Graham F. Healey, Laura J. Peek, and Caroline J. Chapman

Subjects
Pulmonary and Respiratory Medicine, Reproducibility, Pathology, medicine.medical_specialty, Lung, medicine.anatomical_structure, business.industry, medicine, Autoantibody, Decongestive lymphatic therapy, Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, business
Abstract

SD 0.194 0.287 0.194 0.234 0.194 0.198 0.520 0.550 0.279 0.144 p-value NY-ESO-1 mean 1.794 1.803 1.794 1.797 1.794 1.807 1.965 1.997 1.802 1.846 SD 0.306 0.316 0.306 0.323 0.306 0.332 0.561 0.602 0.159 0.199 p-value

Published
2010

5. Early CDT-Lung: QC Measures Reveal High Precision, Accuracy, and Robustness for a Clinical Test To Aid in Early Lung Cancer Detection for High-Risk Individuals

Author

Laura J. Peek, Graham F. Healey, John F.R. Robertson, and Andrea Murray

Subjects
Pulmonary and Respiratory Medicine, Accuracy and precision, Pathology, medicine.medical_specialty, Lung, business.industry, Early lung cancer, Decongestive lymphatic therapy, Critical Care and Intensive Care Medicine, medicine.disease, medicine.anatomical_structure, medicine, Cardiology and Cardiovascular Medicine, Lung cancer, business, Nuclear medicine
Abstract

CAGE. 50 nM 160 nM Batch Slope Intercept r Slope Intercept r #1 0.97 0.04 1.00 0.98 0.06 1.00 #2 0.98 0.02 1.00 0.97 0.04 1.00 #3 0.95 0.06 1.00 0.92 0.11 1.00 #4 0.97 0.05 1.00 0.97 0.07 1.00 #5 0.89 0.17 0.99 0.90 0.17 0.98 #6 0.95 0.05 1.00 0.94 0.06 1.00 Annexin 1 - low Annexin 1 - high

Published
2010

6. An Autoantibody Test (AABT) To Aid in Early Detection of Lung Cancer in High-Risk Patients Is Likely To Be Cost-effective

Author

Herbert Fritsche, James R. Jett, Daniel L. Miller, Frank C. Detterbeck, John F.R. Robertson, Peter Boyle, Geoffrey Hamilton-Fairley, Anne Khuu, Derek Weycker, William C. Wood, Timothy C. Kennedy, and John Edelsberg

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, High risk patients, business.industry, Cost effectiveness, Autoantibody, Early detection, Critical Care and Intensive Care Medicine, medicine.disease, Internal medicine, Autoantibody test, medicine, Cardiology and Cardiovascular Medicine, business, Lung cancer, Lung cancer screening
Published
2010

7. The Presence of Autoantibodies to Tumour-Associated Antigens Can Predate Clinical Diagnosis of Small Cell Lung Cancer

Author

Paul Maddison, Jan J.G.M. Verschuuren, Caroline J. Chapman, Bethan Lang, Maarten J. Titulaer, Gozzard Paul, Alison Thorpe, Andrea Murray, and John F.R. Robertson

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, Autoantibody, Critical Care and Intensive Care Medicine, medicine.disease, Rheumatology, Sample group, City hospital, Antigen, Clinical diagnosis, Internal medicine, medicine, Non small cell, Cardiology and Cardiovascular Medicine, business, Lung cancer
Abstract

Sample Group O D @ 6 5 0 n m The Presence of Autoantibodies to Tumour-Associated Antigens can Predate Clinical Diagnosis of Lung Cancer Caroline Chapman(1), D Isenberg(2), A Murray(3), A Thorpe(1), J McElveen(3), J Allen(3), J Robertson(1) (1) Division of Surgery, School of Clinical Sciences, University of Nottingham, Nottingham UK. (2) Centre For Rheumatology, University of London, UK. (3) Oncimmune Ltd, Nottingham City Hospital, Nottingham, UK. email: caroline.chapman@nottingham.ac.uk

Published
2010

8. Identification of Tumor-Associated Autoantibodies in Small Cell Lung Cancer as Immune Markers of Disease

Author

Paul Maddison, Caroline J. Chapman, John F.R. Robertson, Andrea Murray, Alison Thorpe, and Celine B. Parsy-Kowalska

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, Autoantibody, Immune markers, Disease, Critical Care and Intensive Care Medicine, Confidence interval, Antigen, Internal medicine, Immunology, Medicine, Non small cell, Patient group, Cardiology and Cardiovascular Medicine, business, Normal control
Abstract

The presence of autoantibodies in individuals with SCLC may provide an early indication of disease for high-risk individuals, when the chance of successful treatment would be greatest. Percentage positivity (+ve) with 95% confidence interval (x,y) in each patient group Panel: autoantibody positivity to any one of the six antigens. *Denotes p-value relative to normal control results. *p 0.05 (Chi-squared analysis). Frequency of Autoantibodies to Tumor-Associated Antigens

Published
2010

9. CYSTEINYL LEUKOTRIENE LEVELS IN BRONCHOALVEOLAR LAVAGE FLUID OF PEDIATRIC LUNG TRANSPLANT RECIPIENTS

Author

Binal S. Kancherla, Emmett D. McKenzie, Marc G. Schecter, Okan Elidemir, Minh L. Doan, Jeffrey S. Heinle, Haibin Zhang, John F.R. Robertson, and George B. Mallory

Subjects
Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung, medicine.diagnostic_test, business.industry, medicine.medical_treatment, Critical Care and Intensive Care Medicine, Gastroenterology, medicine.anatomical_structure, Bronchoalveolar lavage, Cysteinyl leukotrienes, Internal medicine, medicine, Lung transplantation, Cardiology and Cardiovascular Medicine, business
Published
2007

Catalog

Books, media, physical & digital resources
See catalog results